Debt-to-equity of Allarity Therapeutics, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Allarity Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
Allarity Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 73%, a 67% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Allarity Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	73%	-146%	-67%	30 Sep 2025
Q2 2025	69%	-779%	-92%	30 Jun 2025
Q1 2025	64%	+548%		31 Mar 2025
Q4 2024	125%	+718%		31 Dec 2024
Q3 2024	218%	+999%		30 Sep 2024
Q2 2024	848%	+3035%		30 Jun 2024
Q1 2024	-484%	-1347%	-156%	31 Mar 2024
Q4 2023	-593%	-821%	-360%	31 Dec 2023
Q3 2023	-780%	-953%	-552%	30 Sep 2023
Q2 2023	-2187%	-2280%	-2446%	30 Jun 2023
Q1 2023	863%			31 Mar 2023
Q4 2022	228%			31 Dec 2022
Q3 2022	173%			30 Sep 2022
Q2 2022	93%			30 Jun 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.